Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer
Clinical trial NCT03098836 · COMPLETED
Trial details
- NCT number
- NCT03098836
- Sponsor
- Daniel George, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-10
- Primary completion
- 2024-07-09
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.